Research Topics
| M M McNeilSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trialNina Marano
Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 300:1532-43. 2008..In 1999, the US Congress directed the Centers for Disease Control and Prevention to conduct a pivotal safety and efficacy study of anthrax vaccine adsorbed (AVA)...- A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?Michael M McNeil
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, United States
Vaccine 30:2421-6. 2012..Within 1-2 days, 13 reservists from the same unit presented to the emergency department and 14 filed Vaccine Adverse Event Reporting System (VAERS) reports of nonspecific symptoms following MIV... 
A comparative assessment of immunization records in the Defense Medical Surveillance System and the Vaccine Adverse Event Reporting SystemMichael M McNeil
Anthrax Vaccine Safety Team, Bacterial Vaccine Preventable Diseases Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, NE, Atlanta, GA 30333, USA
Vaccine 25:3428-36. 2007..Our study is the first to quantify the agreement between immunization records in VAERS and DMSS. Our data suggest the immunization information in military VAERS reports and the DMSS is similar for anthrax and non-anthrax immunizations...- Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997M M McNeil
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Clin Infect Dis 33:641-7. 2001..These data highlight the public health importance of mycotic diseases and emphasize the need for continuing surveillance... - Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967-1972 study and review of the 1955-2005 medical literatureMichael M McNeil
Anthrax Vaccine Safety Team, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 16:259-74. 2007..While some recent anthrax vaccine safety studies have suggested that women experience more injection site reactions (ISRs), to our knowledge the IND safety data were not previously examined for a gender-specific difference... 
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medicationK Galil
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Emerg Infect Dis 5:681-7. 1999..abscessus identical by enzymatic and molecular typing methods. Unusual infectious agents and alternative health practices should be considered in the diagnosis of infections that do not respond to routine treatment...- Candidemia in pediatric outpatients receiving home total parenteral nutritionM V Cano
Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Med Mycol 43:219-25. 2005..Our findings underscore the challenges of maintaining stringent infection control practices in the home health care setting and suggest the need for more intensive follow-up and coordination of home TPN therapy among pediatric patients... - Postsurgical Candida albicans infections associated with an extrinsically contaminated intravenous anesthetic agentM M McNeil
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
J Clin Microbiol 37:1398-403. 1999..We hypothesize that extrinsic contamination of propofol by anesthesiologist 9 likely resulted in C. albicans infections. These data suggest that strict aseptic techniques must be used when preparing and administering propofol... - Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visitsB A Lasker
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Cancer for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Med Mycol 39:341-52. 2001..The adaptation and maintenance of an endogenous C. albicans strain within its host may be linked to as yet uncharacterized factors... - Outbreak of histoplasmosis among cavers attending the National Speleological Society Annual Convention, Texas, 1994D A Ashford
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Am J Trop Med Hyg 60:899-903. 1999.... - Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999George M Lyon
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Am J Trop Med Hyg 70:438-42. 2004..Persons who explore caves, whether for recreation or science, should be aware of the risk bat-inhabited caves pose for developing histoplasmosis, especially if they are immunocompromised in any way... - Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination programGabrielle L Fowler
Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 15:880-8. 2006..Results of this decision-making study may be used to try to improve acceptance rates of AVA among persons considered at high risk, and may inform educational efforts for other adult vaccines... - Assessment of anthrax vaccination data in the Defense Medical Surveillance System, 1998-2004Daniel C Payne
Centers for Disease Control and Prevention, National Immunization Program, Atlanta, Georgia, USA
Pharmacoepidemiol Drug Saf 16:605-11. 2007..S. military from 1998 to 2004... - Phenotypic and molecular epidemiologic evaluation of a Nocardia farcinica mastitis epizooticJune M Brown
Bacterial Zoonoses Branch, Division of Foodborne, Bacterial and Mycotic Diseases, National Center for Zoonotic, Vector Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vet Microbiol 125:66-72. 2007..Our study suggests the epizootic was caused by transmission of a unique clone of N. farcinica through intrinsically contaminated dry cow intramammary products rather than an extrinsic source... - Concurrent vaccinations and U.S. military hospitalizationsDaniel C Payne
Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Ann Epidemiol 17:697-703. 2007..To investigate whether concurrent vaccinations (> or =2 vaccinations on consecutive days) are associated with hospitalization risk among U.S. military personnel... - Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System (DMSS), 1998-2004Jill C Davila
Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, United States
Vaccine 26:1577-84. 2008..4%; 95% CI = 80.1, 86.3); most vaccine categories' conditional sensitivities improved over time. Our study suggests DMSS vaccination data may be acceptable for post-marketing vaccine safety studies for certain vaccines and timeframes... - Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003Daniel C Payne
Bacterial Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Arch Neurol 63:871-5. 2006.... - Characterization of clinical isolates previously identified as Oerskovia turbata: proposal of Cellulosimicrobium funkei sp. nov. and emended description of the genus CellulosimicrobiumJune M Brown
Meningitis and Special Pathogens Branch Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Int J Syst Evol Microbiol 56:801-4. 2006..The definition of this novel Cellulosimicrobium species will assist in the understanding of the epidemiology and clinical significance of these micro-organisms... - Rapid identification of Nocardia farcinica clinical isolates by a PCR assay targeting a 314-base-pair species-specific DNA fragmentJune M Brown
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious DiseCenters for Disease Control and Prevention, Mail Stop G 34, Atlanta, GA 30333, USA
J Clin Microbiol 42:3655-60. 2004..Rapid diagnosis of N. farcinica infection may allow for earlier initiation of effective therapy, thus improving patient outcome... - Trends in prescribing for vulvovaginal candidiasis in the United StatesLinda F McCaig
Ambulatory Care Statistics Branch, Division of Health Care Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, MD 20782, USA
Pharmacoepidemiol Drug Saf 14:113-20. 2005..Since January 1991, intravaginal antifungal medications have been available over-the-counter in the United States to treat vulvovaginal candidiasis... - Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition Mark F Schinsky
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Int J Syst Evol Microbiol 54:1653-67. 2004..n = 1) and Mycobacterium brisbanense sp. nov. (n = 1), with type strains ATCC 49935T (= W5998T = DSM 44677T), ATCC 49403T (= W5198T = DSM 44676T) ATCC 49404T (= W6705T = DSM 44679T) and ATCC 49938T (= W6743T = DSM 44680T), respectively... - An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability programStacey W Martin
Anthrax Vaccine Safety Team, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 14:393-401. 2005..e., ciprofloxacin, doxycycline, or amoxicillin); or (2) 40 additional days of antimicrobial prophylaxis plus three doses of anthrax vaccine adsorbed (AVA)... - Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthraxBruce C Tierney
Epidemiology Program Office, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 37:905-11. 2003..No SAEs were associated with anthrax vaccine. CDC will continue to monitor Program participants during the next 2 years... - Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbedDaniel C Payne
Bacterial Vaccine Preventable Diseases Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Pharmacoepidemiol Drug Saf 16:46-54. 2007..The focus of this report is to describe the process by which the VAU's anthrax vaccine safety research plan was developed following a comprehensive review of these topics... - Phenotypic and genetic characterization of clinical isolates of CDC coryneform group A-3: proposal of a new species of Cellulomonas, Cellulomonas denverensis sp. novJune M Brown
Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, Bldg 17 2207, Mailstop G 34, Atlanta, GA 30333, USA
J Clin Microbiol 43:1732-7. 2005..hominis serve to further clarify the complex taxonomy of CDC coryneform group A-3 bacteria and will assist in our understanding of the epidemiology and clinical significance of these microorganisms... - Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facilityNatalya U Makarova
Laboratory of Bacteriology and Mycology, Department of Laboratory Medicine, Russia AIDS Centre, Central Institute of Epidemiology, Moscow, Russia
J Clin Microbiol 41:1833-7. 2003..There may be a tendency for persons who are living with AIDS in a long-term care facility and who receive fluconazole therapy for oropharyngeal candidiasis to harbor and spread fluconazole-resistant C. albicans strains... - Molecular epidemiologic evaluation of endocarditis due to Oerskovia turbata and CDC group A-3 associated with contaminated homograft valvesMichael M McNeil
National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
J Clin Microbiol 42:2495-500. 2004..turbata and C. hominis and represent a unique clone of CDC group A-3 associated with fatal endocarditis...